STAT+ 人事变动专栏：Vir Biotechnology 聘请 David Liu 出任首席医学官
STAT+: Up and down the ladder: The latest comings and goings
Vir Biotechnology 聘请 David Liu 担任首席医学官，他此前在 Nuvation Bio 担任同一职位。这是 STAT+ 每周人事变动专栏本期重点介绍的人事任命。
By Ed Silverman
Oct. 30, 2026
Pharmalot Columnist, Senior Writer
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter and the afternoon Pharmalot newsletter.
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going.
And here is our regular feature in which we highlight a different person each week. This time around, we note that Vir Biotechnology hired David Liu as chief medical officer. Previously, he worked at Nuvation Bio, where he held the same position.
But all work and no play can make for a dull chief medical officer.
STAT+ Exclusive Story
Already have an account? Log in
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
来源：STAT News · statnews.com